HealthRX.com · Printable medication review sheet
Mounjaro and pregabalin dose-step check-in sheet
One sheet to fill in at each Mounjaro dose step while you take pregabalin: dizziness, sleepiness, falls, low blood sugar, swelling, pain control and kidney results, with the label facts your prescriber will weigh.
Starting point
Pregabalin dose per day and reasondiabetic nerve pain, other nerve pain, fibromyalgia, seizures
Creatinine clearance or eGFR, with date
Falls in the past year
Insulin or sulfonylureaname and dose
At each Mounjaro dose step
| Date | Mounjaro dose (mg) | Dizziness | Sleepiness | Falls or near-falls | Low blood sugar episodes | Ankle or leg swelling | Pain control |
|---|---|---|---|---|---|---|---|
Label facts to weigh
- Pregabalin dizziness and sleepiness usually start soon after beginning it and are more frequent at higher doses.[1]
- The pregabalin label lowers the daily dose range when creatinine clearance is below 60 mL/min.[1]
- Pregabalin can cause serious breathing problems with other medicines that cause severe sleepiness, or in people who already have breathing problems.[1]
- Pregabalin is stopped gradually, over at least 1 week.[1]
- With insulin or a sulfonylurea, Mounjaro can raise the risk of low blood sugar, and a lower dose of those medicines may be needed.[2]
Act promptly on
- Swelling of the face, mouth, lips, gums, tongue, throat or neck, or trouble breathing: stop pregabalin and call right away.[1]
- Sweating, shakiness, confusion, blurred vision or a fast heartbeat can mean low blood sugar, and so can dizziness or drowsiness, which pregabalin also causes: check your glucose if you can.[2]
Questions for this visit
- Can my pregabalin dose stay the same while Mounjaro is increased?
- If my nerve pain improves with better glucose control, can pregabalin be reduced?
- Should my insulin or sulfonylurea dose change when Mounjaro starts?
- How often should my kidney function be rechecked?
Sources for the facts on this sheet
- Viatris Specialty LLC, via DailyMed. Lyrica (pregabalin) capsules and oral solution: prescribing information and Medication Guide. Effective 2025-04-15. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4734e7d-5079-455e-8ff5-8f4539c998a9
- Eli Lilly and Company, via DailyMed. Mounjaro (tirzepatide) injection, for subcutaneous use: prescribing information and Medication Guide. Effective 2026-08-27. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.